From left to right: Alexis Borisy, Zach Weinberg and Christoph Lengauer (Vimeo via website)
February 14, 2023 11:35 AM ESTUpdated February 17, 04:42 AM
Financing

Alex­is Borisy, Zach Wein­berg de­but $520M idea for a new biotech in­vest­ing mod­el

Amber Tong

Alex­is Borisy and Zach Wein­berg first met when they were each lead­ing a com­pa­ny that they co-found­ed. Foun­da­tion Med­i­cine, where Borisy was found­ing CEO and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ideaya inks ADC deal with $75M up­front; Amy­lyx, Gubra to de­vel­op long-act­ing GLP-1

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

De­spite mixed da­ta in Alzheimer's ag­i­ta­tion, Ax­some will still seek FDA ap­proval

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

A service from the Financial Times